Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Mayo Clinic Proceedings|June 1, 1991
Platelet von Willebrand factorH R Gralnick, S B Williams, L P McKeown, et al.
Annals of Internal Medicine|July 1, 1982
NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerationsA S Fauci, J B Harley, W C Roberts, et al.
British Journal of Haematology|March 1, 1992
Endogenous platelet fibrinogen: its modulation after surface expression is related to size-selective access to and conformational changes in the bound fibrinogenH R Gralnick, S B Williams, L McKeown, et al.
Leukemia|July 29, 2000
Hypergranular promyelocytic leukemia: correlation between morphology and chromosomal translocations including t(15;17) and t(11;17)J M Bennett, D Catovsky, M T Daniel, et al.
The American Journal of Medicine|June 1, 1985
Abnormal coagulation results in patients with Hodgkin's diseaseE J Seifter, R I Parker, H R Gralnick, et al.
Cancer|October 1, 1984
Acute megakaryoblastic leukemia in childhoodE Sariban, C Oliver, L Corash, et al.
Thrombosis and Haemostasis|October 1, 1994
Upper extremity impedance plethysmography in patients with venous access devicesM K Horne, D J Mayo, H R Alexander, et al.
American Journal of Hematology|September 1, 1985
Normal human blood density gradient lymphocyte subset analysis: I. An interlaboratory flow cytometric comparison of 85 normal adultsG E Marti, L Magruder, K Patrick, et al.
Thrombosis and Haemostasis|January 1, 1997
Fibrinolytic and coagulant responses to regional limb perfusions of tumor necrosis factor, interferon-gamma, and/or melphalanP Merryman, S H Tannenbaum, H R Gralnick, et al.
Blood|July 1, 1986
Platelet von Willebrand factor: an important determinant of the bleeding time in type I von Willebrand's diseaseH R Gralnick, M E Rick, L P McKeown, et al.
Pageof 15